Chief Scientific Officer · Immuneering Corp (IMRX)

Brett Hall

FY2025 is the first fiscal year CompBrief holds for Brett Hall as a named executive officer of Immuneering; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,289,504

Compensation figures as of the proxy filed April 20, 2026 (DEF 14A).

Brett Hall compensation by year

Immuneering Summary Compensation Table · the one fiscal year held
In US dollars, as Immuneering reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$733,468
Bonus$264,048
Stock awards$0
Option awards$289,752
Non-equity incentive$0
Pension and deferred compensation$0
All other$2,236
Total$1,289,504

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immuneering Corp DEF 14A filed April 20, 2026, accession 0001790340-26-000048, and prior-year filings. Open the filing on EDGAR.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option68,178—$6.09
Option1,732—$9.66
Option50,646—$4.25
Option185,000—$1.91

Per the Outstanding Equity Awards at Fiscal Year-End table in Immuneering Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Immuneering’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Benjamin ZeskindPresident and Chief Executive Officer$1,660,612
Brett Hall · this pageChief Scientific Officer$1,289,504
Michael BookmanChief Legal Officer$890,362

The full Immuneering compensation record

free company brief

This page is one person within Immuneering's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Immuneering's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Immuneering's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy